PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Picard Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$15.45+2.70 (+21.18%)
Close on Oct 19, 2026
- Market cap
- $28.67M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$471.05 (−96.82%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Picard Medical, Inc. grew revenue 41.0% to $6.30M over the twelve months to Jun 30, 2026.
Revenue
$6.30M
+41.0% vs. a year earlier
Operating income
-$15.63M
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $28.67M
- P/E ratio
- –
- Price to sales
- 4.55
- Price to book
- 16.71
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $6.30M
- Net income
- -$27.99M
- Book value per share
- $0.92
- Diluted shares
- 2M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Revenue
$6.30M+41.0% YoY
Gross profit
$1.17M
Operating income
-$15.63M
Net income
-$27.99M
Reported periodTrailing twelve months